| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/14/2005 | EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use |
| 09/14/2005 | EP1572888A2 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 09/14/2005 | EP1572887A2 Neural regeneration peptide and methods for their use in treatment of brain damage |
| 09/14/2005 | EP1572886A2 Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| 09/14/2005 | EP1572885A2 Methods for treating diabetes and other blood sugar disorders |
| 09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
| 09/14/2005 | EP1572878A2 Compositions and methods for inferring a response to a statin |
| 09/14/2005 | EP1572877A2 Drug metabolizing enzymes |
| 09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
| 09/14/2005 | EP1572875A2 Receptors and membrane-associated proteins |
| 09/14/2005 | EP1572872A2 Igs as modifiers of the p53 pathway and methods of use |
| 09/14/2005 | EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 09/14/2005 | EP1572862A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 09/14/2005 | EP1572861A2 Ap1 amine oxidase variants |
| 09/14/2005 | EP1572859A2 Dispersion of carbon nanotubes by nucleic acids |
| 09/14/2005 | EP1572741A1 Therapeutic and diagnostic agents |
| 09/14/2005 | EP1572739A1 Asthma susceptibility locus |
| 09/14/2005 | EP1572738A1 Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
| 09/14/2005 | EP1572730A2 Nact as a target for lifespan expansion and weight reduction |
| 09/14/2005 | EP1572363A2 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon |
| 09/14/2005 | EP1572346A1 Surface treatment |
| 09/14/2005 | EP1572311A2 Assay for determining the activity of fatty acid amide hydrolase |
| 09/14/2005 | EP1572236A2 Levels of pin1 in normal and cancerous tissue |
| 09/14/2005 | EP1572170A2 Immunotoxin as a therapeutic agent and uses thereof |
| 09/14/2005 | EP1572168A2 Anti-infarction molecules |
| 09/14/2005 | EP1572130A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2005 | EP1572124A2 Hcv e1e2 vaccine compositions |
| 09/14/2005 | EP1572122A2 Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides |
| 09/14/2005 | EP1572116A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2005 | EP1572108A2 Functional mutations in respiratory syncytial virus |
| 09/14/2005 | EP1572106A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 09/14/2005 | EP1572105A2 Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr |
| 09/14/2005 | EP1572104A2 Induction of apoptosis by hiv-1 infected monocytic cells |
| 09/14/2005 | EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 09/14/2005 | EP1572100A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 09/14/2005 | EP1572099A2 Screening and therapeutic methods relating to neurogenesis |
| 09/14/2005 | EP1572094A2 Sodium channel alpha subunit variants |
| 09/14/2005 | EP1572092A2 Mk2 interacting proteins |
| 09/14/2005 | EP1572088A2 Use of na,k-atpase a-and b-subunits in bladder cancer detection and drug screening |
| 09/14/2005 | EP1572082A2 Cancer-linked gene as target for chemotherapy |
| 09/14/2005 | EP1572077A2 Uses of monoclonal antibody 8h9 |
| 09/14/2005 | EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation |
| 09/14/2005 | EP1572072A2 Methods of treating infection by drug resistant bacteria |
| 09/14/2005 | EP1572070A2 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 09/14/2005 | EP1572067A2 Conjugates and compositions for cellular delivery |
| 09/14/2005 | EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 09/14/2005 | EP1540321A4 Method and apparatus for manipulating polarizable analytes via dielectrophoresis |
| 09/14/2005 | EP1534073A4 Methods for identifying modulators of mda-7 mediated apoptosis |
| 09/14/2005 | EP1532275A4 Mg-mediated hot start biochemical reactions |
| 09/14/2005 | EP1495137B1 Primer extension based method employing nucleotides labelled via cleavable linkers |
| 09/14/2005 | EP1461617A4 Method of identifying energy transfer sensors for analytes |
| 09/14/2005 | EP1401996A4 Hybridization normalization methods |
| 09/14/2005 | EP1328656A4 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 09/14/2005 | EP1255774B1 Methods for identifying compounds useful for the treatment of obesity involving foxc2 |
| 09/14/2005 | EP1242964B1 A method for the identification of gene transcripts with improved efficiency in the treatment of errors |
| 09/14/2005 | EP1141674B1 A biofouling monitor and methods to monitor or detect biofouling |
| 09/14/2005 | EP1109915B1 Nucleotide sequences for the tal gene |
| 09/14/2005 | EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain |
| 09/14/2005 | EP1049933B1 Measurement of hydride using chemiluminescent acridinium compounds |
| 09/14/2005 | EP0922106B1 Light emitting biosensor |
| 09/14/2005 | EP0904283B1 Human netrin-1 |
| 09/14/2005 | EP0887422B1 Method of determining cholesterol content of high-density lipoproteins |
| 09/14/2005 | CN1668925A Probe carrier and method of producing same |
| 09/14/2005 | CN1668923A DNA micro-array having standard probe and kit including the array |
| 09/14/2005 | CN1668918A 药物发现的方法 The method of drug discovery |
| 09/14/2005 | CN1668767A Antireflective coatings for high-resolution photolithographic synthesis of DNA array |
| 09/14/2005 | CN1668766A Apparatus for polynucleotide detection and quantitation |
| 09/14/2005 | CN1668765A Oligonucleotides for detecting microorganisms |
| 09/14/2005 | CN1668764A SERRS reactive particles |
| 09/14/2005 | CN1668763A 1L1RL-1 as a cardiovascular disease marker and therapeutic target |
| 09/14/2005 | CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets |
| 09/14/2005 | CN1668761A Therapeutic use of selective PDE10 inhibitors |
| 09/14/2005 | CN1668760A Method of decomposing protein with sulfonic acid compound |
| 09/14/2005 | CN1668759A Method of searching substane having antidiabetic activity |
| 09/14/2005 | CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 09/14/2005 | CN1668757A Use of fluorine nmr for high throughput screening |
| 09/14/2005 | CN1668745A transgenic animal for expressing |
| 09/14/2005 | CN1668742A Solid support having electrostatic layer and use thereof |
| 09/14/2005 | CN1668739A Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (NPPase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 09/14/2005 | CN1668738A Two-phase alcohol dehydrogenase-based coupled enzymatic reaction system |
| 09/14/2005 | CN1668641A 截短tau蛋白 Truncated tau protein |
| 09/14/2005 | CN1668635A Novel calpastatin (CAST) alleles |
| 09/14/2005 | CN1668634A Detection of secreted polypeptides |
| 09/14/2005 | CN1667416A Diagnostics and therapeutics for glaucoma |
| 09/14/2005 | CN1667401A Method and apparatus for sequencing polymers through tunneling conductance variation detection |
| 09/14/2005 | CN1667128A Specific gDNA probe for germplasm identification of five kinds of dendrobium |
| 09/14/2005 | CN1667127A Method for testing culture condition for spore production by fungi |
| 09/14/2005 | CN1667122A Pseudomonas Na+/H+ antiporter protein gene and its cloning process |
| 09/14/2005 | CN1219076C Gene Polymorphism detection method based on DNA adaptor |
| 09/14/2005 | CN1219075C Method for constructing detecting system of hepatitis type B virus DNA |
| 09/14/2005 | CN1219074C Non-invasion prenatal monitoring |
| 09/14/2005 | CN1219073C Ultraviolet laser biomone counter |
| 09/14/2005 | CN1219065C Hybrid winter oilseed rape and methods for producing same |
| 09/14/2005 | CN1219058C Primer and method for rapid molecular detection of eelworm |
| 09/13/2005 | US6943417 DNA-based memory device and method of reading and writing same |
| 09/13/2005 | US6943246 3′terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof |
| 09/13/2005 | US6943243 Control of gene expression in eukaryotic cells |
| 09/13/2005 | US6943242 Design of artificial genes for use as controls in gene expression analysis systems |
| 09/13/2005 | US6943241 Full-length cDNA |
| 09/13/2005 | US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist |